International Forum of Allergy & Rhinology· 2020Q1
International consensus statement on allergy and rhinology: rhinosinusitis 2021
- 903citations
- Q1SCImago
- 2020year
Short summary
The ICAR-RS-2021 updates and expands upon the previous consensus statement, introducing over 40 new topics and revising 140 existing ones concerning rhinologic disease.
AI-generated from the title and abstract; the full text is not read.
Key points
- ICAR-RS-2021 incorporates over 180 topics, including more than 40 new areas and updates to 140 original topics.
- The executive summary presents grade A/B recommendations for 22 medical and 4 surgical management topics related to rhinosinusitis (RS).
- A comprehensive evidence-based management algorithm for RS is provided.
- The document reflects significant advancements in the understanding and treatment of rhinologic disease since the first ICAR-RS publication.
AI-generated from the title and abstract; the full text is not read.
Abstract
I. EXECUTIVE SUMMARY: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document. METHODS: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. RESULTS: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided. CONCLUSION: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.
The authors' abstract, as published at the source. International Forum of Allergy & Rhinology, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Otorhinolaryngology
OtorhinolaryngologyMedicine